Related Experiment Video
Updated: Aug 15, 2026

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Long time due: reducing tuberculosis mortality in the 21st century
Timothy F Brewer1, S Jody Heymann
1Department of Medicine, Mount Auburn Hospital, Brigham and Women's Hospital and Harvard Medical School, Cambridge, Massachusetts 02138, USA. tbrewer@mah.harvard.edu
Abstract:
The beginning and the end of the 20th century were marked by great pandemics: influenza and AIDS. Medical journals do not describe any major tuberculosis (TB) pandemics in the 20th century. Yet TB likely was responsible for more deaths in the last 100 years than influenza and HIV combined. Steadily, insidiously, millions of people die from TB every year. Even under optimal TB control conditions, it is estimated that more than 50 million people will die from TB between 1998 and 2020. Under current TB control conditions, the number is closer to 70 million. It is long past time that the global community committed to a serious program to eliminate tuberculosis mortality. Such a program would require making treatment universally available, making prevention accessible to those in poor countries as well as affluent, addressing the interaction between HIV and TB, and setting serious verifiable goals. A global 5 x 7 initiative that calls for treating an additional 5 million active TB cases per year, and for screening up to five contacts of every TB case, by 2007 would offer an important beginning. With the sustained effort that comes from public commitment, TB can be changed from one of the most important causes of preventable death worldwide to a historical cause of death. Without this effort, TB will remain the silent, steady killer it has been for centuries. The rationale for action, potential and need for success are detailed in this article.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: